Technology News and Research

RSS

Food Technology Service second-quarter revenues increase to $761,230

Food Technology Service, Inc. had revenues of $761,230 during the second quarter of 2010 compared to revenues of $652,724 for the same period in 2009. This is an increase of approximately 16.4 percent. The Company had net income before taxes during the second quarter of 2010 of $277,624 compared to net income of $165,926 during the second quarter of 2009. This is an increase of approximately 67.3 percent.

16 Aug 2010

Michigan Accelerator Fund 1 launched to support early stage life science and technology companies

Michigan Accelerator Fund I, L.P., today announced the formation of the community's first venture capital fund formed specifically to support early stage life science and technology companies: the Michigan Accelerator Fund 1 (MAF1).

16 Aug 2010

Emisphere second-quarter net loss increases to $13.7 million

Emisphere Technologies, Inc. today announced financial and operational results for the three and six months ended June 30, 2010.

16 Aug 2010

Medco Health Solutions to acquire United BioSource Corporation

Medco Health Solutions, Inc. and United BioSource Corporation today announced a definitive agreement under which Medco will acquire closely held UBC in an all-cash transaction valued at approximately $730 million. The combination of America's leading advanced pharmacy with one of the world's most respected sources of post-approval drug and device research extends Medco's core capabilities in data analytics and research to further accelerate pharmaceutical knowledge – advancing patient safety and furthering evidence-based medicine.

16 Aug 2010

Orthofix launches FUSION XT knee brace with new AirTech system

Orthofix International announced today that its Sports Medicine Division, Breg, has launched the FUSION® XT knee brace with its innovative new AirTech™ system. Designed to improve comfort and fit, AirTech is a complete system of air mesh vents and grooved channel frame pads that increase airflow throughout the brace. The system allows cool air in and moves warm air and moisture away from the skin, improving patient comfort. The new pad technology is also designed to reduce pinching and help alleviate pressure points.

16 Aug 2010

Enrollment open in Phase I clinical study of Morphotek's MORAb-028 for advanced melanoma

Morphotek, Inc., a subsidiary of Eisai Inc., announced today that the John Wayne Cancer Institute in Santa Monica, California has opened enrollment in a Phase I clinical study with MORAb-028 in patients with advanced melanoma.

16 Aug 2010

FDA grants Microsulis Medical 510(k) clearance for Acculis Accu2i percutaneous microwave tissue ablation system

Microsulis Medical Limited, the leading company in microwave technology for medical devices, today announced that the U.S. Food and Drug Administration (FDA) has provided the company 510(k) clearance to market the Acculis Accu2i percutaneous microwave tissue ablation (pMTA) system for the coagulation of soft tissue during surgical procedures.

16 Aug 2010

Dynasil third-quarter revenue increases 33% to $11.3 million

Dynasil Corporation of America today announced record financial results for its 2010 third quarter, which ended June 30, 2010. The Company posted record revenue for the 2010 third quarter of $11.3 million which compares to $8.5 million in the third-quarter of 2009, a 33% increase year over year. Operating income, net income and diluted earnings per share for the quarter were $1.33 million, $727,646, and $0.05, increases of 92%, 85%, and 120%, respectively, compared with the prior year.

16 Aug 2010

Alverix and BD partner to develop point of care infectious disease diagnostic assay systems

As consumers begin to take greater ownership of their own healthcare, there is a growing demand for accessibility to diagnostic testing. Alverix, Inc. and BD (Becton, Dickinson and Company) are on the cutting edge of this trend and today announced an agreement to produce assay systems at the point-of-care (POC) that will improve infectious disease diagnoses.

From BD (Becton, Dickinson and Company) 16 Aug 2010

Indiana University installs new DeltaVision|OMX imaging system from Applied Precision

Applied Precision, along with Indiana University, are excited to announce the installation of a new DeltaVision|OMX imaging system in the Light Microscopy Imaging Center in Bloomington, Indiana.

16 Aug 2010

Weikang Bio-Technology second-quarter revenue decreases 20.5% to $10.5 million

Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced its fiscal 2010 second quarter results for period ended June 30, 2010.

16 Aug 2010

Massachusetts General Hospital implants Levacor Ventricular Assist Device

World Heart Corporation, a developer of mechanical circulatory systems, announced today that the Massachusetts General Hospital in Boston, Mass. has successfully implanted its first Levacor™ Ventricular Assist Device (VAD). Mass General is the fifth implanting site nationwide in the Levacor VAD Bridge-to-Transplant (BTT) Study. This is the eleventh implant with the Levacor VAD since the inception of the BTT study.

16 Aug 2010

ePlus Technology renews IT products and services agreement with VHA

ePlus inc. today announced that its wholly owned subsidiary, ePlus Technology, Inc., has renewed its agreement with VHA Inc., a nationwide network of not-for-profit hospitals that work together to improve clinical and economic performance. ePlus will offer IT products and services as well as leasing services for IT and medical equipment to more than 1,400 VHA member healthcare institutions and 28,000+ non-acute facilities nationwide.

16 Aug 2010

Align Technology releases Invisalign G3 for greater predictability of tooth movements

Align Technology, Inc. today announced the launch of Invisalign® G3, the most significant collection of new features and innovations in the company's history. Invisalign G3 is engineered to deliver even better clinical results, with new aligner and software features that make it easier to use Invisalign with Class II and Class III patients, new SmartForce™ features designed for increased predictability of certain tooth movements, and simpler, more intuitive software to streamline treatment planning and review.

16 Aug 2010

NeoStem second-quarter revenues increase 26% to $19.4 million

NeoStem, Inc. an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.

16 Aug 2010

PLC Systems second-quarter total revenues decrease to $1,019,000

PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today reported financial results for the three- and six month periods ended June 30, 2010.

16 Aug 2010

Cryo-Cell International engages investment bank to evaluate strategic acquisition opportunities

Cryo-Cell International, Inc., one of the world's largest and most established family cord blood banks today announced that it has engaged Morgan Joseph LLC, a full service investment bank, to evaluate strategic acquisition opportunities available to enhance value for Cryo-Cell's shareholders.

16 Aug 2010

Arrayit announces addition of 128 new products to life sciences tools portfolio

Arrayit Corporation, a leader in life sciences and healthcare technology, announces today that the company has added 128 new products to its widely-used portfolio of life sciences tools. Arrayit now offers 836 life sciences products to researchers worldwide, all of which can be purchased on-line 24 hours a day at the Arrayit Store. The company has recorded $36.2M in product revenue in the Arrayit Store since its inception.

16 Aug 2010

MEDNAX acquires Laredo-based pediatric cardiology physician group

MEDNAX, Inc., today announced the acquisition of a pediatric cardiology physician group based in Laredo, TX.

16 Aug 2010

NIDA grants Selecta Biosciences $3M to develop nicotine vaccine for smoking cessation and relapse prevention

Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines and immunotherapies, today announced that it has been awarded a grant for $3 million from the National Institute on Drug Abuse (NIDA), an institute within the U.S. National Institutes of Health. The grant is aimed at advancing the development of an enhanced therapeutic nicotine vaccine for the treatment of smoking cessation and relapse prevention.

16 Aug 2010

Technology News and Research

Food Technology Service second-quarter revenues increase to $761,230

Michigan Accelerator Fund 1 launched to support early stage life science and technology companies

Emisphere second-quarter net loss increases to $13.7 million

Medco Health Solutions to acquire United BioSource Corporation

Orthofix launches FUSION XT knee brace with new AirTech system

Enrollment open in Phase I clinical study of Morphotek's MORAb-028 for advanced melanoma

FDA grants Microsulis Medical 510(k) clearance for Acculis Accu2i percutaneous microwave tissue ablation system

Dynasil third-quarter revenue increases 33% to $11.3 million

Alverix and BD partner to develop point of care infectious disease diagnostic assay systems

Indiana University installs new DeltaVision|OMX imaging system from Applied Precision

Weikang Bio-Technology second-quarter revenue decreases 20.5% to $10.5 million

Massachusetts General Hospital implants Levacor Ventricular Assist Device

ePlus Technology renews IT products and services agreement with VHA

Align Technology releases Invisalign G3 for greater predictability of tooth movements

NeoStem second-quarter revenues increase 26% to $19.4 million

PLC Systems second-quarter total revenues decrease to $1,019,000

Cryo-Cell International engages investment bank to evaluate strategic acquisition opportunities

Arrayit announces addition of 128 new products to life sciences tools portfolio

MEDNAX acquires Laredo-based pediatric cardiology physician group

NIDA grants Selecta Biosciences $3M to develop nicotine vaccine for smoking cessation and relapse prevention

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News